Author:
Groselj Ales,Krzan Mojca,Kosjek Tina,Bosnjak Masa,Sersa Gregor,Cemazar Maja
Funder
Javna Agencija za Raziskovalno Dejavnost RS
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference32 articles.
1. Fyfe AJ, McKay P (2010) Toxicities associated with bleomycin. J R Coll Phys Edinb 40:213–215. doi: 10.4997/JRCPE.2010.306
2. Della Latta V, Cecchettini A, Del Ry S, Morales MA (2015) Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions. Pharmacol Res 97:122–130. doi: 10.1016/j.phrs.2015.04.012
3. Pron G, Mahrour N, Orlowski S, Tounekti O, Poddevin B, Belehradek J, Mir LM (1999) Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol 57:45–56. doi: 10.1016/S0006-2952(98)00282-2
4. Sugiura Y, Uesawa Y, Takahashi Y, Kuwahara J, Golik J, Doyle TW (1989) Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics. Proc Natl Acad Sci USA 86:7672–7676
5. Ferrando AA, Velasco G, Campo E, Lopez-Otin C (1996) Cloning and expression analysis of human bleomycin hydrolase, a cysteine proteinase involved in chemotherapy resistance. Cancer Res 56:1746–1750
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献